← Leaderboards
Rashmi S. Hegde
Children'S Hospital Med Ctr (Cincinnati)
$11,628,819
Attributed
$12,208,354
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $993.1K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$12,208,354 · 7
By mechanism
R01$11,797,729 · 6
R21$410,625 · 1
Top collaborators
- Richard A Lang4 shared
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseProteinsGeneticLeadPathway InteractionsMolecularProtein Tyrosine PhosphataseBiochemicalIn VivoIn VitroCellsStructureDiabetic RetinopathyAngiogenesisBlood VesselsBiologyInhibitor/AntagonistCell MotilityPhosphoric Monoester HydrolasesRetinalDna RepairEndothelial CellsHypoxiaBiochemistry
Grant awards (35)
A ROLE FOR EYA3 IN VASCULAR REMODELING AND PULMONARY ARTERIAL HYPERTENSION$533,566
R01 · FY2023 · HL · contact PI
A ROLE FOR EYA3 IN VASCULAR REMODELING AND PULMONARY ARTERIAL HYPERTENSION$543,274
R01 · FY2022 · HL · contact PI
A ROLE FOR EYA3 IN VASCULAR REMODELING AND PULMONARY ARTERIAL HYPERTENSION$636,205
R01 · FY2021 · HL · contact PI
Linked regulation of tumor angiogenesis and chemo-resistance$356,850
R01 · FY2021 · CA · contact PI
A ROLE FOR EYA3 IN VASCULAR REMODELING AND PULMONARY ARTERIAL HYPERTENSION$636,205
R01 · FY2020 · HL · contact PI
Linked regulation of tumor angiogenesis and chemo-resistance$356,850
R01 · FY2020 · CA · contact PI
Linked regulation of tumor angiogenesis and chemo-resistance$346,144
R01 · FY2019 · CA · contact PI
Linked regulation of tumor angiogenesis and chemo-resistance$356,850
R01 · FY2018 · CA · contact PI
Linked regulation of tumor angiogenesis and chemo-resistance$356,850
R01 · FY2017 · CA · contact PI
Mechanism of action of Retinal Determination proteins$351,000
R01 · FY2017 · EY · contact PI
EYA in Retinal Angiogenesis$382,500
R01 · FY2016 · EY · contact PI
Mechanism of action of Retinal Determination proteins$351,000
R01 · FY2016 · EY · contact PI
EYA in Retinal Angiogenesis$374,850
R01 · FY2015 · EY · contact PI
Mechanism of action of Retinal Determination proteins$343,980
R01 · FY2015 · EY · contact PI
EYA in Retinal Angiogenesis$374,850
R01 · FY2014 · EY · contact PI
Mechanism of action of Retinal Determination proteins$351,000
R01 · FY2014 · EY · contact PI
EYA in Retinal Angiogenesis$382,500
R01 · FY2013 · EY · contact PI
Molecular Mechanisms of Retinal Determination Proteins$360,000
R01 · FY2012 · EY · contact PI
Molecular Mechanisms of Retinal Determination Proteins$360,000
R01 · FY2011 · EY · contact PI
Molecular Mechanisms of Retinal Determination Proteins$375,000
R01 · FY2010 · EY · contact PI
CRIM1-b-Catenin-Cadherin Interactions in Eye Development and Disease$373,445
R01 · FY2010 · EY
Eyes Absent phosphatase inhibitors in eye disease$185,625
R21 · FY2010 · EY · contact PI
CRIM1-b-Catenin-Cadherin Interactions in Eye Development and Disease$375,000
R01 · FY2009 · EY
Eyes Absent phosphatase inhibitors in eye disease$225,000
R21 · FY2009 · EY · contact PI
Mechanism of Action of Retinal Determination Proteins$319,028
R01 · FY2008 · EY · contact PI
Mechanism of Action of Retinal Determination Proteins$325,540
R01 · FY2007 · EY · contact PI
Mechanism of Action of Retinal Determination Proteins$327,372
R01 · FY2006 · EY · contact PI
Mechanism of Action of Retinal Determination Proteins$335,250
R01 · FY2005 · EY
DNA Target Selection by Papillomavirus E2 Proteins$245,680
R01 · FY2005 · CA
Mechanism of Action of Retinal Determination Proteins$335,250
R01 · FY2004 · EY
DNA Target Selection by Papillomavirus E2 Proteins$245,680
R01 · FY2004 · CA
DNA Target Selection by Papillomavirus E2 Proteins$245,680
R01 · FY2003 · CA
DNA Target Selection by Papillomavirus E2 Proteins$245,680
R01 · FY2002 · CA
DNA Target Selection by Papillomavirus E2 Proteins$156,969
R01 · FY2001 · CA
DNA Target Selection by Papillomavirus E2 Proteins$137,681
R01 · FY2001 · CA